Legend Biotech Corporation
LEGN
$35.46
-$0.17-0.48%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 255.06M | 194.96M | 186.30M | 159.92M | 184.10M |
| Total Other Revenue | 3.00K | 90.00K | 224.00K | 281.00K | 2.42M |
| Total Revenue | 255.06M | 195.05M | 186.52M | 160.21M | 186.52M |
| Cost of Revenue | 196.29M | 173.27M | 178.35M | 150.99M | 163.08M |
| Gross Profit | 58.77M | 21.79M | 8.17M | 9.21M | 23.45M |
| SG&A Expenses | 80.65M | 72.43M | 83.13M | 79.57M | 65.42M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 276.94M | 245.70M | 261.48M | 230.56M | 228.49M |
| Operating Income | -21.88M | -50.65M | -74.96M | -70.36M | -41.97M |
| Income Before Tax | -124.80M | -99.13M | 40.51M | -120.89M | -17.97M |
| Income Tax Expenses | 582.00K | 1.79M | 14.23M | 4.44M | 226.00K |
| Earnings from Continuing Operations | -125.38M | -100.92M | 26.28M | -125.32M | -18.20M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -125.38M | -100.92M | 26.28M | -125.32M | -18.20M |
| EBIT | -21.88M | -50.65M | -74.96M | -70.36M | -41.97M |
| EBITDA | -19.50M | -48.24M | -72.06M | -67.98M | -38.82M |
| EPS Basic | -1.36 | -1.10 | 0.29 | -1.37 | -0.20 |
| Normalized Basic EPS | -0.42 | -0.33 | 0.15 | -0.41 | -0.06 |
| EPS Diluted | -1.36 | -1.10 | 0.29 | -1.37 | -0.20 |
| Normalized Diluted EPS | -0.42 | -0.33 | 0.14 | -0.41 | -0.06 |
| Average Basic Shares Outstanding | 184.14M | 183.76M | 183.32M | 183.28M | 182.60M |
| Average Diluted Shares Outstanding | 92.07M | 91.88M | 100.70M | 91.64M | 91.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |